Otsuka (OTCMKTS:OTSKY) Trading Up 8.6% – Here’s What Happened

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) were up 8.6% on Tuesday . The company traded as high as $34.05 and last traded at $34.05. Approximately 1,027 shares traded hands during trading, a decline of 97% from the average daily volume of 35,667 shares. The stock had previously closed at $31.36.

Analysts Set New Price Targets

Several research firms have recently commented on OTSKY. Zacks Research downgraded Otsuka from a “hold” rating to a “strong sell” rating in a report on Monday, March 2nd. Morgan Stanley raised shares of Otsuka to an “overweight” rating in a research report on Friday, January 23rd. The Goldman Sachs Group lowered shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a research note on Friday, February 27th. Finally, UBS Group raised shares of Otsuka to a “hold” rating in a research note on Tuesday, January 27th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce”.

Otsuka Price Performance

The business has a 50-day moving average of $30.79 and a 200 day moving average of $28.85.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.